Time course of 75%-100% efficacy response of adjunctive brivaracetam.
Pavel KleinCédric LaloyauxSami ElmouftiTeresa GasallaMelinda S MartinPublished in: Acta neurologica Scandinavica (2020)
The majority of patients achieving 75%-100% sustained seizure frequency reduction (all focal seizure types and the subpopulation with FBTCS) with oral BRV (100 or 200 mg/d) achieved this response on the first-treatment day.